Pharmaceuticals, Biotechnology and Life Sciences
– Results published in first paper from 18-month analysis of ongoing pivotal Phase 3 trial were generally consistent with overall…
− New England Journal of Medicine publishes primary endpoint analysis from ongoing Phase 3 study of Takeda’s dengue vaccine candidate…
Sanofi’s dengue vaccien Dengvaxia was approved in the USA, the company said in a press release Thursday.
Sanofi said on Wednesday it would ask health authorities to update information provided to physicians and patients on its dengue…
Sanofi Pasteur, the vaccines division of Sanofi, has gotten from Brayil regulatory approval to Dengvaxia. As the company said Monday ,…